A new heart monitoring system combining 3D printing and artificial intelligence could transform the way doctors measure and diagnose patients’ heart health. Developed at SFU’s School of Mechatronic Systems Engineering,… Read More
Province-wide partnership brings faster, more accessible innovative research testing method to patients living with MS New Brunswick is breaking new ground in Multiple Sclerosis (MS) care with the launch of… Read More
VANCOUVER, BC – NervGen Pharma Corp. (“NervGen” or the “Company”) , a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other traumatic and neurologic disorders,… Read More
A new mobile app, REACHOUT, is helping people with type 1 diabetes (T1D) in rural and remote communities access mental health support. In T1D, the body can’t make insulin. Insulin… Read More
Data demonstrate a favorable bioavailability profile of INM-901 oral formulation Data will support design and planning of first in human clinical trials Preparing for pre-IND meeting with the FDA Vancouver,… Read More
